Anat Bel-Ange

Anat Bel-Ange

Auto-generated profile, based on publicly available information

Anat Bel-Ange

Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Hebrew University of Jerusalem Faculty of Medicine , Jerusalem 91120

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2026 in Journal of the Endocrine Society
Verified
Journal Article
Open access
KSKalyan Mansukhbhai Shekhda
Kalyan Mansukhbhai Shekhda
JHJohn Howat
John Howat
YGYujia Gao
Yujia Gao
ABAnat Bel-Ange
Anat Bel-Ange
SGSimona Glasberg
Simona Glasberg
AGAshley B Grossman
Ashley B Grossman
Introduction: Pancreatic neuroendocrine tumors (pNETs) are a recognized feature of tuberous sclerosis complex (TSC). The current evidence suggests that pNETs occurring in TSC may exhibit a different clinical course from sporadic cases, but their natural history remains poorly characterized. Objective: This study aimed to characterize the demographics, clinical presentation, management, and long-term outcomes of TSC-associated-pNETs and to propose possible guidelines for surveillance and management. Materials and Methods: We conducted a multicenter retrospective review of TSC-pNET patients from 6 UK TSC specialist clinics and from 3 NET referral centers, from 2008 to 2024. Data on demographics, tumor characteristics, management, and outcomes, were collected. A systematic review of the literature from 2009 to 2026 on TSC-pNETs was also performed. Results: We identified a total of 26 consecutive cases with the TSC-pNET-association in our cohort: 21 cases of pNETs from TSC specialist clinics (1.1% of the population), and 5 cases of TSC-pNETs from the NET referral centers (0.25% of the population). An additional 80 cases were identified from the published literature. We observed a wide spectrum of clinical phenotypes, with the majority being nonfunctioning pNETs (n = 24; 92%), whereas 2 patients were diagnosed with glucagonomas. Surgical intervention was the mainstay initial treatment, the indication being either functional pNETs, or large or symptomatic nonfunctioning pNETs. Conclusion: TSC-pNETs are rare and mostly nonfunctioning tumors with variable clinical behavior. Due to their uncertain malignant potential, we suggest that baseline pancreatic imaging should be incorporated into TSC surveillance, and we emphasize the need for heightened pNET surveillance and updated management recommendations.

15 June 2026 in European Journal of Endocrinology
Verified
Journal Article
Open access
AMA Malczewska-Herman
A Malczewska-Herman
ARAnja Rinke
Anja Rinke
PHPernille Holmager
Pernille Holmager
MOMarta Opalinska
Marta Opalinska
MMMairead Mcnamara
Mairead Mcnamara
BKBeata Kos-Kudła
Beata Kos-Kudła
Objective: Most neuroendocrine neoplasms (NENs) are sporadic and occur predominantly in older patients. Early-age disease onset has been increasingly observed in NENs. We aimed to assess the clinical features and outcomes of young adults with sporadic NENs. Design: This is a retrospective study which gathered 20 institutions from 12 countries under the auspices of Women in NET (WiN) ENETS group. Methods: Young patients aged 18-40 years diagnosed with sporadic NENs (well- and poorly-differentiated) from 2010-2020 were enrolled. Patients with appendiceal and type 1 gastric NETs, hereditary syndromes, synchronous malignancy, phaeochromocytoma, paraganglioma, and medullary thyroid cancer, were excluded. Descriptive statistics, comparisons between groups, survival and Cox multivariable analysis were performed. Results: Overall, 478 young patients with sporadic NENs were enrolled. Localised (62%, n=249), well-differentiated (92%, n=433), non-functioning tumours (81%, n=384) and women (58%, n=277) were more prevalent. The pancreas was the most common primary site (33%, n=159). Metastatic disease at diagnosis was more often found in men than women (47%, n=78 vs. 33%, n=78, p=0.004). Five-year OS was 82%. OS was significantly longer in women than men (p=0.019), as well as in rectal (p=0.00245) and lung (p=0.0027) primary tumours compared to pancreatic NENs. The multivariable analysis identified stage, Ki-67, morphology and gender as independent predictors of survival. Conclusions: Young patients with NENs often present with well-differentiated and localised tumours, thereby increasing the probability of curative surgical resection. Prospective research into molecular biology is needed to identify distinct NEN features in young adults and determine risk factors to tailor effective treatment strategies.